Publication
Promoter Methylation of HOXA5 and NDRG2 in Multiple Myeloma Patients with Renal Impairment.
Riham Abdel-Hamid Haroun, Dina Samir Elsaid, Mona A Al-Dosoky, Tamer A Elbedewy, Sally M Gamal-Eldin, Rabab A Keshk
Biochemical geneticsOct 1, 2026PMID 42258087doi:10.1007/s10528-026-11401-6 Journal ArticlepubmedProvenance
- Source
- PubMed
- Retrieved
- Oct 1, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20261001-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Renal impairment (RI) is frequently caused by multiple myeloma (MM), which makes clinical care more difficult if renal function deteriorates or renal failure develops. Thus, in this investigation, we looked at the relationship between HOXA5&NDRG2 promoter methylation in MM patients and evaluated…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMultiple Myelomadictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.